Amino Innovations Launches Wholesale Program to Bring Human Peptide Science to Clinics, Retailers., and Wellness Centers Nationwide

(TheNewswire)

Vancouver, British Columbia– December 2, 2025 – TheNewswire - PangeaWellness Inc. (CSE: PNGA) (OTC: PNGAF)(“ Pangea ” or the “ Company ”), is pleased to announce that itssubsidiary, Amino Innovations Inc. (“Amino Innovations”), hasofficially launched its U.S. wholesale and B2B distribution program,expanding access to its growing line of non-injectable, peptide-basedwellness products.

This new program introduces a comprehensivedistribution model that brings advanced peptide formulations intoprofessional environments that have traditionally relied on injectabletherapies. Many clinics, wellness centers, and performance facilitiesare familiar with peptides administered through traditional injectionprotocols. Amino Innovations is now providing a more accessiblealternative through premium oral capsules, topical creams, hairserums, and its upcoming flagship Peptide Patch product line.

Additionally, the program allows participating clinicsand retailers to promote Amino Innovations products through on-siteeducational materials and mock packaging. All fulfilment, e-commercelogistics, customer support, and compliance requirements are manageddirectly by Amino Innovations through its integrated online platformand United States distribution network.

“Our mission is to make human peptide scienceaccessible and simple for practitioners and consumers,” said DamonMichaels, President and Co-Founder of Amino Innovations. “We overseeall operational and compliance functions to ensure a seamlessexperience for our partners, which allows them to focus on supportingtheir clients while introducing a new potential revenue stream and ahigher level of customer experience.”

The wholesale program is suited to a wide range ofprofessional and retail environments seeking to integratescience-backed, non-injectable peptide products. Ideal partnersinclude integrative and functional medicine clinics, regenerative andlongevity centers, IV therapy and wellness lounges, sports medicineand recovery facilities, med spas, dermatology and aesthetic clinics,biohacking and fitness studios, and pharmacy or apothecary styleboutiques. These settings are well positioned to feature AminoInnovations product, which complement traditional peptide programswhile offering broader accessibility for everyday use.

All Amino Innovations peptide-based formulations aremanufactured in cGMP certified facilities in the United States.Products are third party tested and formulated exclusively with humanendogenous peptides including BPC-157, GHK Cu, Epitalon, Pinealon,Thymosin Alpha 1, and Thymosin Beta 4.

Clinics and retailers interested in joining the AminoInnovations wholesale network can learn more or apply atAminoInnovations.com/wholesale.

About Pangea Wellness Inc.

Pangea Wellness Inc. is a North American manufacturerspecializing in clean-label foods and innovative wellness products.Through its subsidiary Amino Innovations, the Company offers advanced,non-injectable peptide delivery systems that support recovery,cognitive function, and overall health.

On Behalf of the Board ofDirectors

"PratapSandhu"

Pratap Sandhu
CEO, Corporate Secretary and Director

+1 (604) 765-8069
media@pangea-wellness.com

Forward-Looking Information

This news release containsforward–looking statements and forward–looking information withinthe meaning of applicable securities laws. These statements relate tofuture events or future performance. All statements other thanstatements of historical fact may be forward–looking statements orinformation. Forward-looking statements in this news release includestatements related to Amino Innovation’s wholesale distributionprogram and the anticipated benefits from the wholesale distributionprogram. The forward–looking statements and information are based oncertain key expectations and assumptions made by the management of theCompany. As a result, there can be no assurance that the acquisitionor related matters will be completed as proposed or at all. Althoughmanagement of the Company believes that the expectations andassumptions on which such forward-looking statements and informationare based are reasonable, undue reliance should not be placed on theforward–looking statements and information since no assurance can begiven that they will prove to be correct.

Forward-looking statements andinformation are provided for the purpose of providing informationabout the current expectations and plans of management of the Companyrelating to the future. Readers are cautioned that reliance on suchstatements and information may not be appropriate for other purposes,such as making investment decisions. Since forward–lookingstatements and information address future events and conditions, bytheir very nature they involve inherent risks and uncertainties.Actual results could differ materially from those currentlyanticipated due to a number of factors and risks. These include, butare not limited to, the ability of the Company to complete its plannedfuture activities and anticipated business plans. Other factors mayalso adversely affect the future results or performance of theCompany, including general economic, market or business conditions,changes in the financial markets and changes in laws, regulations andpolicies affecting the Company's operations and theCompany's limited operating history. Accordingly, readers shouldnot place undue reliance on the forward–looking statements andinformation contained in this news release. Readers are cautioned thatthe foregoing list of factors is not exhaustive. The forward–looking statements and information contained in this news release aremade as of the date hereof and no undertaking is given to updatepublicly or revise any forward–looking statements or information,whether as a result of new information, future events or otherwise,unless so required by applicable securities laws. The forward-lookingstatements or information contained in this news release are expresslyqualified by this cautionary statement.

Copyright (c) 2025 TheNewswire - All rights reserved.